Family Medicine · Elberton, GA
NPI
1700883659
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
109 College Ave
Elberton, GA, 30635
Phone (706) 283-3315
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
355 services
Medicare patients, 2024
142
Average age 77
Drug cost, 2024
$2.0M
39,450 prescriptions
Company payments, 2025
$1,580
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark L Daniel was code 71046 (x-ray - chest), 56 times for 53 patients. In total Mark L Daniel billed 355 services in 27 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 71046 X-ray - Chest | Office | 56 | 53 | $10.67 | $598 |
| 85610 Clinical Chemistry | Office | 50 | 11 | $4.20 | $210 |
| 93005 Electrocardiogram | Office | 45 | 41 | $3.12 | $140 |
| 99308 SNF E&M | Facility | 35 | 13 | $55.30 | $1,936 |
| 99309 SNF E&M | Facility | 24 | 11 | $80.27 | $1,926 |
| 81001 Clinical Chemistry | Office | 20 | 17 | $3.11 | $62.2 |
| 99233 Hospital E&M - Subsequent | Facility | 15 | 11 | $83.93 | $1,259 |
By year: 2022 $22K for 628 services; 2023 $14K for 437 services; 2024 $11K for 355 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 50 | 11 | $4.20 | $210 |
| 81001 Clinical Chemistry | 20 | 17 | $3.11 | $62.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark L Daniel prescribed most often to Medicare patients was Famotidine, with 1,491 prescriptions and refills. In total Mark L Daniel wrote 39,450 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 1,491 | 1,771 | 138 | $14K |
| Amlodipine Besylate Generic | 1,273 | 1,957 | 184 | $5,990 |
| Atorvastatin Calcium Generic | 1,263 | 2,371 | 233 | $8,327 |
| Furosemide Generic | 1,211 | 1,693 | 165 | $5,110 |
| Levothyroxine Sodium Generic | 1,162 | 1,697 | 140 | $7,611 |
| Gabapentin Generic | 1,123 | 1,270 | 133 | $13K |
| Potassium Chloride Generic | 1,086 | 1,355 | 111 | $12K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 975 | 976 | 156 | $27K |
| Alprazolam Generic | 762 | 764 | 77 | $2,524 |
| Pravastatin Sodium Generic | 675 | 759 | 45 | $6,493 |
| Eliquis Apixaban | 583 | 615 | 39 | $156K |
| Omeprazole Generic | 538 | 786 | 81 | $5,841 |
| Mirtazapine Generic | 533 | 555 | 33 | $5,487 |
| Lisinopril Generic | 530 | 887 | 87 | $2,660 |
| Donepezil Hcl Generic | 493 | 517 | 22 | $6,314 |
Brand drugs: 4,366 claims; generic drugs: 34,851 claims; opioid claims: 1,987.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark L Daniel $1,580 ($1,580 in general payments such as food, travel and fees) from 20 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $227.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 10 | $227 |
| Axsome Therapeutics, Inc. AXSM | 9 | $180 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 8 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $114 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $103 |
| Novo Nordisk Inc NVO | 6 | $98.85 |
| Pfizer Inc. PFE | 5 | $96.82 |
| Exact Sciences Corporation EXAS | 4 | $83.6 |
| Lilly USA, LLC LLY | 4 | $65.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.